Novo CEO pressed by Senate to cut price ranges of obesity, diabetic issues medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the business would take into account new talks with insurers in regards to the listing prices of Wegovy and copyright when they pledge to help keep the medicines on their https://kethek.com/